Institutions / Logos Global Management LP
Logos Global Management LP
CIK 1792126 · Institution · as of Dec 31, 2025
Portfolio value
$1.50B
Positions
64
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 64 →
| Company | Value | % of portfolio |
|---|---|---|
| Revolution Medicines, Inc. | $159.30M | 10.6% |
| Praxis Precision Medicines, Inc. | $110.53M | 7.4% |
| Ideaya Biosciences, Inc. | $108.03M | 7.2% |
| Olema Pharmaceuticals, Inc. | $80.22M | 5.3% |
| Cidara Therapeutics Inc | $68.48M | 4.6% |
| Abivax SA | $53.94M | 3.6% |
| Erasca, Inc.ERAS | $48.36M | 3.2% |
| Ocular Therapeutix, Inc | $42.49M | 2.8% |
| Structure Therapeutics Inc.GPCR | $41.73M | 2.8% |
| Disc Medicine, Inc.IRON | $40.50M | 2.7% |
| Maze Therapeutics, Inc. | $39.36M | 2.6% |
| Tango Therapeutics, Inc. | $37.21M | 2.5% |
| Avidity Biosciences, Inc. | $36.06M | 2.4% |
| Biogen Inc. | $35.20M | 2.3% |
| Immunovant, Inc.IMVT | $34.95M | 2.3% |
| Jazz Pharmaceuticals PLC | $34.00M | 2.3% |
| Terns Pharmaceuticals, Inc. | $30.30M | 2.0% |
| Vaxcyte, Inc. | $29.99M | 2.0% |
| Immunocore Holdings Plc-AdrIMCR | $29.50M | 2.0% |
| Lb Pharmaceuticals IncLBRX | $26.71M | 1.8% |
| Dyne Therapeutics, Inc. | $24.45M | 1.6% |
| Design Therapeutics, Inc.DSGN | $23.45M | 1.6% |
| MoonLake ImmunotherapeuticsMLTX | $23.07M | 1.5% |
| ACADIA Pharmaceuticals Inc | $22.70M | 1.5% |
| Rhythm Pharmaceuticals, Inc. | $20.34M | 1.4% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.